3.0.0 3199 2022-11-01T07:02:35Z 2022-11-01T07:02:35Z House HR 2019-06-11 116 [Congressional Record Volume 165, Number 97 (Tuesday, June 11, 2019)][House]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Mr. JEFFRIES:H.R. 3199.Congress has the power to enact this legislation pursuantto the following:Article 1, Section 8, Clause 8[Page H4432]]]> hsju00 Judiciary Committee House Standing hsju03 Courts, Intellectual Property, and the Internet Subcommittee Referred to 2019-06-28T17:19:29Z Referred to 2019-06-11T14:00:52Z 2019-06-28 hsju03 Courts, Intellectual Property, and the Internet Subcommittee 1 House committee actions Referred to the Subcommittee on Courts, Intellectual Property, and the Internet. Committee 2019-06-11 Referred to the House Committee on the Judiciary. IntroReferral H11100 2 House floor actions hsju00 Judiciary Committee 2019-06-11 Introduced in House IntroReferral Intro-H 9 Library of Congress 2019-06-11 Introduced in House IntroReferral 1000 9 Library of Congress J000294 Rep. Jeffries, Hakeem S. [D-NY-8] Hakeem Jeffries D NY S. 8 N C001093 Rep. Collins, Doug [R-GA-9] Doug Collins R GA 9 2019-06-11 True M001207 Rep. Mucarsel-Powell, Debbie [D-FL-26] Debbie Mucarsel-Powell D FL 26 2019-06-11 True C001118 Rep. Cline, Ben [R-VA-6] Ben Cline R VA 6 2019-06-11 True R000614 Rep. Roy, Chip [R-TX-21] Chip Roy R TX 21 2019-07-30 False R000515 Rep. Rush, Bobby L. [D-IL-1] BOBBY RUSH D IL L. 1 2019-09-19 False Commerce Congressional oversight Department of Commerce Evidence and witnesses Government studies and investigations Intellectual property Prescription drugs Commerce 00 2019-06-11 Introduced in House 2020-08-08T15:30:17Z Terminating the Extension of Rights Misappropriated Act of 2019 or the Term Act of 2019

This bill addresses double patenting with respect to drug-related patents. Specifically, the bill requires an owner of drug-related patents, if the owner lists more than one patent as covering a particular drug, to prove in certain proceedings that each patent covers a distinct invention. If the patent owner fails to do so, then the owner shall have disclaimed patent protection from all the listed patents after the first patent expires.

This requirement shall apply to various proceedings challenging the validity of drug-related patents, as well as to infringement lawsuits filed by the patent owner against companies seeking Food and Drug Administration approval for generic or biosimilar versions of patented drugs.

The bill also directs the U.S. Patent and Trademark Office (USPTO) to review its examination procedures to prevent granting multiple patents for the same drug or biological product, unless the patents cover distinct inventions. The USPTO shall report to Congress its findings and recommendations from the review.

]]> Term Act of 2019 Display Title Term Act of 2019 Official Title as Introduced To amend title 35, United States Code, to prevent double patenting, and for other purposes. Introduced in House IH Short Title(s) as Introduced Term Act of 2019 Introduced in House IH Short Title(s) as Introduced Terminating the Extension of Rights Misappropriated Act of 2019 Introduced in House IH Introduced in House 2019-06-11T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-116hr3199ih/xml/BILLS-116hr3199ih.xml 2019-06-28 Referred to the Subcommittee on Courts, Intellectual Property, and the Internet. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.